Differential expression of matrix metalloproteinases and their tissue inhibitors in colon mucosa of patients with inflammatory bowel disease.
about
MEP1A allele for meprin A metalloprotease is a susceptibility gene for inflammatory bowel diseaseTumour necrosis factor alpha converting enzyme (TACE) activity in the colonic mucosa of patients with inflammatory bowel diseaseDissection of the inflammatory bowel disease transcriptome using genome-wide cDNA microarraysWound repair: role of immune-epithelial interactionsThe behavior of matrix metalloproteinases and their inhibitors in colorectal cancerAlterations in programmed cell death mechanism and their role in the pathogenesis of inflammatory bowel diseasesOsteopontin and mucosal protectionMilk casein-based diet containing TGF-beta controls the inflammatory reaction in the HLA-B27 transgenic rat modelGlobal gene expression analysis of the mouse colonic mucosa treated with azoxymethane and dextran sodium sulfateImbalance of tissue inhibitors of metalloproteinases (TIMP) - 1 and - 4 serum levels, in patients with inflammatory bowel diseaseThe dissemination of C10 cysteine protease genes in Bacteroides fragilis by mobile genetic elementsTumor imaging by means of proteolytic activation of cell-penetrating peptidesInterleukin (IL)-23 mediates Toxoplasma gondii-induced immunopathology in the gut via matrixmetalloproteinase-2 and IL-22 but independent of IL-17.The impact of serine protease HtrA in apoptosis, intestinal immune responses and extra-intestinal histopathology during Campylobacter jejuni infection of infant miceClinical significance of expression of tissue factor and tissue factor pathway inhibitor in ulcerative colitisEtiopathogenesis of inflammatory bowel diseasesExpression of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 in ulcerative colitisPathophysiology of fistula formation in Crohn's disease.Role of matrix metalloproteinase, tissue inhibitor of metalloproteinase and tumor necrosis factor-alpha single nucleotide gene polymorphisms in inflammatory bowel diseaseMatrix metalloproteinase 9 contributes to gut microbe homeostasis in a model of infectious colitis.Expression of matrix metalloproteinase-1 and tumor necrosis factor-alpha in ulcerative colitis.The complement anaphylatoxin C3a receptor (C3aR) contributes to the inflammatory response in dextran sulfate sodium (DSS)-induced colitis in mice.Gene expression changes in the colon epithelium are similar to those of intact colon during late inflammation in interleukin-10 gene deficient mice.Selective gelatinase inhibition reduces apoptosis and pro-inflammatory immune cell responses in Campylobacter jejuni-infected gnotobiotic IL-10 deficient mice.Dietary uptake of Wedelia chinensis extract attenuates dextran sulfate sodium-induced colitis in miceReview article: Esomeprazole--enhanced bio-availability, specificity for the proton pump and inhibition of acid secretion.Genetic polymorphisms of matrix metalloproteinase 3 in primary sclerosing cholangitis.Interleukin 18 is a primary mediator of the inflammation associated with dextran sulphate sodium induced colitis: blocking interleukin 18 attenuates intestinal damage.Reversal of abnormal collagen production in Crohn's disease intestinal biopsies treated with regenerating agents.Expression and localisation of matrix metalloproteinases and their natural inhibitors in fistulae of patients with Crohn's disease.Fistulising Crohn's disease: MMPs gone awry.Expression and regulation of tissue inhibitor of metalloproteinase-1 and matrix metalloproteinases by intestinal myofibroblasts in inflammatory bowel diseaseCorrelation of MMP-3 and MMP-9 with Crohn's disease activity in childrenResults of the Fifth Scientific Workshop of the ECCO (II): Pathophysiology of Perianal Fistulizing Disease.Review article: gastric pH -- the most relevant predictor of benefit in reflux disease?Preventative oral methylthioadenosine is anti-inflammatory and reduces DSS-induced colitis in mice.Immune markers and differential signaling networks in ulcerative colitis and Crohn's diseaseMatrix Metalloproteinase-2 Mediates Intestinal Immunopathogenesis in Campylobacter Jejuni-Infected Infant Mice.Matrix metalloproteinases in the restorative proctocolectomy pouch of pediatric ulcerative colitisPlasma matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 as biomarkers of ulcerative colitis activity.
P2860
Q24657607-AB303E92-6FA7-45C7-B7AE-97BF0487123BQ24669999-328FB2E6-506C-4A9D-A6FB-D994F883BF5DQ24814806-92F10366-800B-413D-8188-F90476ED33F1Q26801818-85F4F01F-F5D0-45F3-8309-BA313ED02DD5Q27004958-4347EDE7-E24C-4017-AA0B-D4A456B54326Q27016000-7270740C-7D9C-4FFE-BDC8-120ED9E10345Q28236080-1598614C-7590-4D05-97A0-79FD17448529Q28573216-C59ADDDC-C714-4922-9A40-F351DEDFBE12Q33284842-BF5E1268-440A-42AC-848D-CA04C6B9ECBCQ33387401-69CCAAE9-248C-4B48-A9C6-C658B2DEC790Q33563189-181B1CD4-45A9-4FBE-AAD4-3966406BB9CAQ33569121-8901F031-65CE-411F-9D89-4B56B1C6CCE0Q33590409-297826E4-60C4-4181-82AF-48B85AE250B7Q33692376-1C12CC71-6CFB-4706-BFBC-B7A93ECDE5AEQ33780202-0A6DF2C1-196B-4741-A9D2-A0720039B629Q33866988-2C63E9DD-7A61-4D03-857F-9A34EDEECD4AQ34013098-B1B4A5CA-8186-4057-898C-A6A51A66CDD1Q34047996-59F925AC-9DF4-4D8F-A0BC-BF26B3EC8D67Q34224754-018AD8AE-E666-4039-9CDC-CF149626664CQ34302957-CE176161-F4D2-4826-A9AE-7807C2EA1D96Q34382826-8A268106-133A-4174-8609-666A5BE5A372Q34701117-8A07BCFD-1746-43EA-9918-8C1A315CA078Q34735028-1454688F-E3B9-44F5-9B58-18CAA0AFDE15Q34743065-050DADD8-CC4C-4E74-97C3-A99E2816107AQ34755383-78F5CB3C-E564-4B6C-8A54-F6A22160A638Q35080058-ED68A763-8A06-45AA-A5B5-4EFDDBE22BBFQ35114053-4DEBA03E-88C6-4373-8713-4C38A4F4D0EEQ35594688-B0EC397B-D7AF-4115-BB10-414FED80BBFBQ35596217-6F51A904-EDF4-49FC-81D8-D213E02914CDQ35596475-891D74F8-CA2D-482F-9F10-F065F89F0738Q35745017-DAB68B39-14C6-4FBC-85F4-71E972317307Q35749265-70241ACB-EF17-4645-A275-73AA6D3D8F62Q35767203-3BB86E23-F996-480C-97F6-4B8A91780F57Q35872741-887FAA7E-E0A5-4ADB-AA8E-FB74FB1964E1Q35904901-18B83944-B50E-4D27-944E-224874BA975EQ36114931-FFA316B4-A0E6-4BBD-B26D-5692DD0E67F0Q36125752-ACB235EB-1B23-4C41-A202-508A8EDDCEF4Q36139449-A3620105-E675-40C3-9F9B-961010A257CAQ36166985-2B9AC353-CF38-48D0-915D-5A3CBC9BB490Q36180595-0FDAFFBA-FE3B-465C-BCE8-E72EACBE06F2
P2860
Differential expression of matrix metalloproteinases and their tissue inhibitors in colon mucosa of patients with inflammatory bowel disease.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Differential expression of mat ...... th inflammatory bowel disease.
@en
type
label
Differential expression of mat ...... th inflammatory bowel disease.
@en
prefLabel
Differential expression of mat ...... th inflammatory bowel disease.
@en
P2093
P2860
P356
P1433
P1476
Differential expression of mat ...... th inflammatory bowel disease.
@en
P2093
Riecken EO
Rosewicz S
von Lampe B
P2860
P356
10.1136/GUT.47.1.63
P407
P577
2000-07-01T00:00:00Z